News
Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations. A phase II trial of TAS-102 in patients with colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback